Vandana Singh

Vandana Singh

Benzinga Editor

About
Vandana Singh, MBA Finance is an Editor of the Benzinga Breaking News. Vandana has been covering the healthcare sector for over 10 years, including providing support services to renowned investment banks.
Eli Lilly's Commercial Moat, Competitor Landscape: BofA Emphasizes Strength in Incretin Space, Undervalued Assets
Women's History Month: Pharmacy Chains CVS Health, Walgreens To Start Dispensing Abortion Pill Mifepristone In Select States
Investment Advisor Vanguard's CEO Tim Buckley To Step Down, Search For Successor Underway
Deal On Cards? Boeing Explores Reacquiring Spirit AeroSystems Amidst Quality Concerns, Production Challenges
Why Is Gritstone Bio Stock Trading Lower?
Small Cap-Cardiff Oncology Outlines Data From Discontinued Colorectal Cancer Trial, Stock Soars
Why Is Generic Drug-Focused Amneal Pharmaceuticals Stock Trading Lower Friday?
What's Going With UnitedHealth Stock On Friday?
Why Is Alzheimer's/Parkinson's Focused BioVie Stock Surging On Friday?
Truck/Bus Manufacturer Lion Electric Reports Disappointing Q4 Earnings, Stock Tumbles
Pfizer's Respiratory Syncytial Virus Vaccine Maintains Staying Power In Older Adults Through 2nd RSV season, Study Finds
Challenging Times For Definitive Healthcare: Analysts Highlight Sluggish Growth And Recovery Efforts In Q4 Analysis
Why Is Kidney-Disease Diagnostic Focused Renalytix Stock Trading Higher Today?
Advil Maker Haleon Expects Higher 2024 Revenue After Strong 2023 Earnings, Stock Soars
Why Is Amarin Stock Trading Lower After Q4 Earnings?
Why Is Gastrointestinal Healthcare Focused Ironwood Pharmaceuticals Stock Sinking On Thursday?
Generic/Biosimilar Player Sandoz Settles US Price Fixing Case For $265M
Why Is Biotech/Pharma Contract Service Provider Societal CDMO Stock Trading Higher On Thursday?
Elon Musk-Backed Neuralink's Animal Studies Have Red Flags, FDA Uncovers Deficiencies
GSK Settles Another California Lawsuit On Heartburn Drug Zantac Causing Cancer, Second Within A Month